TG Therapeutics Inc
TGTX31.070USD
+0.340+1.11%
Close 12/24, 16:00（ET）Quotes delayed by 15 min
4.82BMarket Cap
10.15P/E TTM
TG Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
329.00M
40.80%
EPS(YoY)
0.16
80.25%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its total revenue reached 329.00M, with a year-on-year change of 40.80%.
What is the Earnings Per Share (EPS) of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.161, with a year-on-year change of 80.25%.
What is the net income of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its net income was 23.38M, with a year-on-year change of 84.52%.
What is the net margin of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its net profit margin was 7.11%, with a year-on-year change of 31.05%.
What is the gross margin of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its gross margin was 88.30%, with a year-on-year change of -6.01%.
What is the debt-to-asset ratio of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 42.31%, with a year-on-year change of 39.29%.
What is the Return on Equity (ROE) of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 12.21%, with a year-on-year change of 5.59%.
What is the Return on Assets (ROA) of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 5.15%, with a year-on-year change of 6.40%.
What is the operating profit of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its operating profit was 41.93M, with a year-on-year change of 103.21%.
What are the current assets of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its current assets were 566.36M, with a year-on-year change of 78.13%.
What are the total assets of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its total assets of TG Therapeutics Inc were 577.69M, with a year-on-year change of 75.28%.
What are the total liabilities of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its total liabilities of TG Therapeutics Inc were 355.33M, with a year-on-year change of 110.15%.
What is the total equity of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its total equity of TG Therapeutics Inc was 222.36M, with a year-on-year change of 38.54%.
What is the net operating income of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its net operating income of TG Therapeutics Inc was 23.38M, with a year-on-year change of 84.52%.
What is the net investment of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its net investment of TG Therapeutics Inc was -1.04M, with a year-on-year change of 97.95%.
What is the net financing of TG Therapeutics Inc?
According to TG Therapeutics Inc's FY2024 earnings report, its net financing of TG Therapeutics Inc was 128.53M, with a year-on-year change of 76.78%.
